Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Issue 2

The role of health systems and hospital administrative system in Covid-19 pandemic period is of utmost importance.
Objective: The scope of study is to assess the preparedness, response competencies of administrative staff and resilience of health system as well as to highlight the need of modernizing the role of the above three com­ponents. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

COVID-19 has been a global challenge caused by a coronavirus that infects the respiratory system and poses a high risk to life. This study dealt with some immunological indicators associated with this disease Continue reading

Τόμος 34 (2020) – Τεύχος 3 –Άρθρο 5 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 34 (2020) – Issue 3 – Article 5 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The current transmission of Coronavirus Disease (COVID-19) has raised multiple concerns across all over the world. Until now, no effective treatment has been established for COVID-19 and this virus may also affect young people or people who do not belong to a vulnerable group. Continue reading

Volume 37 (2023) – Issue 2 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Cardiovascular diseases (CVDs) remain a significant global health concern, contributing to substantial morbidity and mortality.
Continue reading

Volume 37 (2023) – Issue 2 – Article 2– Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The global COVID-19 pandemic has posed significant challenges to healthcare systems worldwide. Vulnerable populations, such as individuals with underlying health conditions, are particularly at risk. Continue reading

Volume 37 (2023) – Issue 2 – Article 5 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The incidence of emerging infectious diseases has increased during the past two decades and is expected to further increase. Continue reading